OAK BROOK, Ill.--(BUSINESS WIRE)--Relief Mental Health, a leading outpatient provider of transcranial magnetic stimulation (TMS), psychedelic therapy (SPRAVATO® and IV ketamine), psychiatry services, and talk therapy, now offers TMS treatment for smoking cessation in its Oak Brook, Ill. clinic.
Utilizing state-of-the-art BrainsWay Deep TMS™ technology, this advanced therapy is now available to help individuals overcome their addiction to nicotine.
Deep TMS is a non-invasive, FDA-approved treatment that targets the neural pathways associated with smoking addiction. By gently stimulating specific areas of the brain, Deep TMS helps reduce cravings and withdrawal symptoms, making it easier for patients to quit smoking. With a proven track record of success, Deep TMS offers new hope for those struggling to break free from the cycle of addiction.
In Illinois, an individual who smokes a pack of cigarettes daily can expect to spend nearly $4,000 per year. Further, the state's annual healthcare costs directly attributed to smoking amount to $6.38 billion, while smoking-related productivity losses in Illinois reach $13.7 billion, according to the Campaign for Tobacco-Free Kids.
The financial burden, coupled with the well-known health risks of smoking, makes quitting an urgent priority for many. TMS treatment provides a powerful tool for those who have tried other methods without success. The benefits of quitting smoking are undeniable: reduced risk of heart disease, stroke, lung cancer, and a longer, healthier life.
"Our mission has always been to offer the most effective treatments available to help our patients lead healthier lives," said Susan Mueller, founder and CEO of Relief Mental Health. "With TMS for smoking cessation, we are providing a groundbreaking solution that addresses the root of nicotine addiction. This treatment empowers our patients to finally achieve their goal of becoming smoke-free."
A BrainsWay study demonstrated a significant improvement in the continuous quit rate, as well as a substantial reduction in cravings and number of cigarettes smoked. Deep TMS has been shown to be well-tolerated, causing no systemic side effects.
In addition to smoking cessation, Deep TMS is FDA-approved for treating depression, obsessive-compulsive disorder (OCD), and anxious depression, where anxiety occurs alongside depression. These effective treatments are available at all 10 of Relief's clinics and are covered by most insurance plans, including Medicare and Tricare.
Relief also offers rapid-acting psychedelic therapy, including SPRAVATO®—a prescription nasal spray form of ketamine and the first psychedelic drug approved by the FDA for treating severe depression. Additionally, Relief provides ketamine infusions in Oak Brook, addressing diagnoses such as depression, PTSD, bipolar depression, anxiety, and more. Both modalities are provided in a controlled clinical environment, ensuring that each treatment is administered under the careful supervision of a licensed medical professional. This approach prioritizes patient safety while leveraging the therapeutic potential of these advanced treatments for those who may benefit from them.
Anyone interested in learning more about these innovative treatment options can contact Relief Mental Health at 855.205.4764 or info@reliefmh.com to schedule a consultation.
About Relief Mental Health
Relief Mental Health is a leading outpatient provider of transcranial magnetic stimulation (TMS), psychedelics (SPRAVATO® and IV ketamine), psychiatric medication management, and talk therapy, for the treatment of depression, obsessive compulsive disorder, anxiety and other diagnoses. Founded in January 2020 and dedicated to delivering expedited care, Relief has 10 outpatient centers in three states. In Illinois, clinics are located in Chicago (Lakeview and West Loop), Oak Brook, Orland Park, Northbrook, Rockford, and St. Charles. Relief’s other clinics are in Red Bank and Warren, New Jersey, and West Allis, Wisconsin. Relief Mental Health aims to create a new standard of mental health care by offering a continuum of innovative therapeutic interventions and responding to evolving patient needs. For more information, visit www.reliefmh.com.
